v3.25.2
Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders’ Deficit - USD ($)
Preferred Stock
Series A Convertible
Preferred Stock
Series B Convertible
Preferred Stock
Series C/C-1 Convertible
Common Stock
NorthView Acquisition Corp
Common Stock
Additional Paid-In Capital
NorthView Acquisition Corp
Additional Paid-In Capital
Accumulated Deficit
NorthView Acquisition Corp
Accumulated Deficit
NorthView Acquisition Corp
Total
Balance Beginning at Dec. 31, 2022 $ 5,231,000 $ 13,701,000 $ 46,217,000 $ 519 $ 5,676,000 $ (619,995) $ (105,447,000) $ (619,476) $ (99,771,000)
Balance Beginning (in Shares) at Dec. 31, 2022 4,350,314 5,293,175 8,220,445 5,193,750 5,570,901            
Issuance of common stock upon exercise of stock options     23,000     23,000
Issuance of common stock upon exercise of stock options (in Shares)   33,750            
Stock-based compensation expense     33,000     33,000
Accretion of common stock to redemption value           (2,137,638)   (2,137,638)  
Excise tax payable attributable to redemption of common stock           (1,864,106)   (1,864,106)  
Net income (loss) 1,161,910 (10,281,000) 1,161,910 (10,281,000)
Balance Ending at Dec. 31, 2023 $ 5,231,000 $ 13,701,000 $ 46,217,000 $ 519 5,732,000 (3,459,829) (115,728,000) (3,459,310) $ (109,996,000)
Balance Ending (in Shares) at Dec. 31, 2023 4,350,314 5,293,175 8,220,445 5,193,750 5,604,651            
Issuance of common stock upon exercise of stock options (in Shares)                    
Stock-based compensation expense     5,000     $ 5,000
Accretion of common stock to redemption value           (205,732)   (205,732)  
Excise tax payable attributable to redemption of common stock           (10,884)   (10,884)  
Net income (loss) (820,277) (2,385,000) (820,277) (2,385,000)
Balance Ending at Mar. 31, 2024 $ 5,231,000 $ 13,701,000 $ 46,217,000 $ 519 5,737,000 (4,496,722) (118,113,000) (4,496,203) (112,376,000)
Balance Ending (in Shares) at Mar. 31, 2024 4,350,314 5,293,175 8,220,445 5,193,750 5,604,651            
Balance Beginning at Dec. 31, 2023 $ 5,231,000 $ 13,701,000 $ 46,217,000 $ 519 5,732,000 (3,459,829) (115,728,000) (3,459,310) (109,996,000)
Balance Beginning (in Shares) at Dec. 31, 2023 4,350,314 5,293,175 8,220,445 5,193,750 5,604,651            
Issuance of common stock upon exercise of stock options        
Issuance of common stock upon exercise of stock options (in Shares)                    
Stock-based compensation expense     21,000     $ 21,000
Accretion of common stock to redemption value           (768,980)   (768,980)  
Excise tax payable attributable to redemption of common stock           (16,838)   (16,838)  
Net income (loss) (8,711,619) (9,230,000) (8,711,619) (9,230,000)
Balance Ending at Dec. 31, 2024 $ 5,231,000 $ 13,701,000 $ 46,217,000 $ 519 5,753,000 (12,957,266) (124,958,000) (12,956,747) $ (119,205,000)
Balance Ending (in Shares) at Dec. 31, 2024 4,350,314 5,293,175 8,220,445 5,193,750 5,604,651            
Issuance of common stock upon exercise of stock options (in Shares)                    
Stock-based compensation expense     5,000     $ 5,000
Accretion of common stock to redemption value           (155,999)   (155,999)  
Excise tax payable attributable to redemption of common stock           (65,108)   (65,108)  
Net income (loss) (1,119,910) (2,716,000) (1,119,910) (2,716,000)
Balance Ending at Mar. 31, 2025 $ 5,231,000 $ 13,701,000 $ 46,217,000 $ 519 $ 5,758,000 $ (14,298,283) $ (127,674,000) $ (14,297,764) $ (121,916,000)
Balance Ending (in Shares) at Mar. 31, 2025 4,350,314 5,293,175 8,220,445 5,193,750 5,604,651